609 related articles for article (PubMed ID: 31252032)
1. IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis.
Callewaert C; Nakatsuji T; Knight R; Kosciolek T; Vrbanac A; Kotol P; Ardeleanu M; Hultsch T; Guttman-Yassky E; Bissonnette R; Silverberg JI; Krueger J; Menter A; Graham NMH; Pirozzi G; Hamilton JD; Gallo RL
J Invest Dermatol; 2020 Jan; 140(1):191-202.e7. PubMed ID: 31252032
[TBL] [Abstract][Full Text] [Related]
2. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment.
Simpson EL; Schlievert PM; Yoshida T; Lussier S; Boguniewicz M; Hata T; Fuxench Z; De Benedetto A; Ong PY; Ko J; Calatroni A; Rudman Spergel AK; Plaut M; Quataert SA; Kilgore SH; Peterson L; Gill AL; David G; Mosmann T; Gill SR; Leung DYM; Beck LA
J Allergy Clin Immunol; 2023 Nov; 152(5):1179-1195. PubMed ID: 37315812
[TBL] [Abstract][Full Text] [Related]
3. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis.
Hartmann J; Moitinho-Silva L; Sander N; Harder I; Häsler R; Rodriguez E; Haufe E; Kleinheinz A; Abraham S; Heratizadeh A; Weisshaar E; Schäkel K; Handrick C; Augustin M; Wollenberg A; Staubach-Renz P; Ertner K; Sticherling M; Schwarz B; Quist S; Wiemers F; Schenck F; Wildberger J; Tittmann L; Lieb W; Schmitt J; Werfel T; Weidinger S;
Allergy; 2023 Aug; 78(8):2290-2300. PubMed ID: 37032440
[TBL] [Abstract][Full Text] [Related]
6. The adaptive immune system in atopic dermatitis and implications on therapy.
Roesner LM; Werfel T; Heratizadeh A
Expert Rev Clin Immunol; 2016 Jul; 12(7):787-96. PubMed ID: 26967382
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.
Gonzalez ME; Schaffer JV; Orlow SJ; Gao Z; Li H; Alekseyenko AV; Blaser MJ
J Am Acad Dermatol; 2016 Sep; 75(3):481-493.e8. PubMed ID: 27543211
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab for the treatment of adolescents with atopic dermatitis.
Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
[TBL] [Abstract][Full Text] [Related]
9. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
[TBL] [Abstract][Full Text] [Related]
10. Changes in Skin and Nasal Microbiome and Staphylococcal Species Following Treatment of Atopic Dermatitis with Dupilumab.
Olesen CM; Ingham AC; Thomsen SF; Clausen ML; Andersen PS; Edslev SM; Yüksel YT; Guttman-Yassky E; Agner T
Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361924
[TBL] [Abstract][Full Text] [Related]
11. Drug evaluation review: dupilumab in atopic dermatitis.
Hamilton JD; Ungar B; Guttman-Yassky E
Immunotherapy; 2015; 7(10):1043-58. PubMed ID: 26598956
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin.
Leung DYM; Bissonnette R; Kreimer S; Berdyshev E; Bafna S; Lyubchenko T; Richers BN; Garcia S; Ramirez-Gama M; Hall CF; Xiao O; Taylor P; Boguniewicz M; Levit NA; Agueusop I; Zhang A; Goleva E
J Allergy Clin Immunol Pract; 2023 May; 11(5):1421-1428. PubMed ID: 36958520
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab: Basic aspects and applications to allergic diseases.
Matsunaga K; Katoh N; Fujieda S; Izuhara K; Oishi K
Allergol Int; 2020 Apr; 69(2):187-196. PubMed ID: 32007360
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Oral Vitamin D Supplement on Atopic Dermatitis: A Clinical Trial with Staphylococcus aureus Colonization Determination.
Udompataikul M; Huajai S; Chalermchai T; Taweechotipatr M; Kamanamool N
J Med Assoc Thai; 2015 Oct; 98 Suppl 9():S23-30. PubMed ID: 26817206
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab.
Mikhaylov D; Del Duca E; Olesen CM; He H; Wu J; Ungar B; Estrada Y; Zhang N; Chowdhury M; Clausen ML; Krueger JG; Pavel AB; Agner T; Guttman-Yassky E
Dermatitis; 2021 Oct; 32(1S):S71-S80. PubMed ID: 34405829
[TBL] [Abstract][Full Text] [Related]
18. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.
He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E
Front Immunol; 2020; 11():1768. PubMed ID: 32849633
[TBL] [Abstract][Full Text] [Related]
19. Combining 16S Sequencing and qPCR Quantification Reveals
De Tomassi A; Reiter A; Reiger M; Rauer L; Rohayem R; Ck-Care Study Group ; Traidl-Hoffmann C; Neumann AU; Hülpüsch C
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509067
[TBL] [Abstract][Full Text] [Related]
20. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
